OncLiveDr. Socinski on Milestone of Immunotherapy in Lung CancerOncLive2015 was a monumental year because the community saw the approval of 2 immunotherapy drugs, nivolumab (Opdivo) and pembrolizumab (Keytruda)that replaced the former standard of care,… Continue reading
|
Northern Colorado Doctor Kenneth Pettine Releases Information on Mesenchymal Stem Cell Therapy for Chronic Neck …
Benzinga Dr. Kenneth Pettine, a board certified retired Orthopedic Surgeon and one of the Top 50 Spine Surgeons and Specialist to Know according to Becker’s Spine Review, is offering to educate the public about mesenchymal stem cell therapy in Northern Colorado. |
PharmaTimes |
Scottish universities link to develop stem cell therapies
PharmaTimes The UK Regenerative Medicine Platform-funded “Engineering and exploiting the stem cell niche” Hub, led by the CRM, is dedicated to increase understanding of the biology of stem cell niches and to exploiting this knowledge therapeutically to improve … |
Cambridge News |
Cambridge man Jacob Gray who received life-saving stem cell transplant gears up for London Marathon
Cambridge News A Cambridge man who received a life-saving stem cell transplant from his sister is taking part in the London Marathon to raise money for blood cancer charity Anthony Nolan. Jacob Gray, 31, of Chesterton was diagnosed with non-Hodgkin’s lymphoma when … |
Cambridge News |
Cambridge man Jacob Gray who received life-saving stem cell transplant gears up for London Marathon
Cambridge News A Cambridge man who received a life-saving stem cell transplant from his sister is taking part in the London Marathon to raise money for blood cancer charity Anthony Nolan. Jacob Gray, 31, of Chesterton was diagnosed with non-Hodgkin’s lymphoma when … |
|
Gene Therapies: A Diverse Range of Technologies with a Promising …
Medgadget (blog) The latest report on, “Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook” provides information about all gene therapies un. |
Proactive Investors Australia |
Cynata Therapeutics talks stem cell research at Proactive’s CEO Sessions
Proactive Investors Australia The technology addresses a critical shortcoming in existing methods of production of mesenchymal stem cells (MSCs) for therapeutic use. Cynata is now in a transition to a clinical stage company. Earlier this year Cynata announced a breakthrough … |